EPITHELIOID SARCOMA
Clinical trials for EPITHELIOID SARCOMA explained in plain language.
Never miss a new study
Get alerted when new EPITHELIOID SARCOMA trials appear
Sign up with your email to follow new studies for EPITHELIOID SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug offered as last hope for rare cancer patients
Disease control AVAILABLEThis program provides special access to an experimental drug called ubamatamab for patients with two rare and aggressive cancers: renal medullary carcinoma and epithelioid sarcoma. It is designed for individuals who have exhausted all standard treatment options and cannot join re…
Matched conditions: EPITHELIOID SARCOMA
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with aggressive, rare cancers
Disease control Recruiting nowThis study is testing whether three drugs given together can treat rare and aggressive childhood cancers caused by missing specific proteins. It will first find the safest dose and then see if the combination effectively controls these difficult tumors. The trial is for children …
Matched conditions: EPITHELIOID SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Susan Chi, MD • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New pill tested in fight against Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing a new oral medication called HH2853 in adults with advanced cancers that have come back or stopped responding to standard treatments. The main goals are to find a safe and tolerable dose and to see if the drug shows any early signs of helping to …
Matched conditions: EPITHELIOID SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for kids with aggressive cancers: trial tests supercharged immune transplant
Disease control Recruiting nowThis study is testing a new type of stem cell transplant for children and young adults whose solid tumors have returned or not responded to standard treatments. Doctors are using a donor's stem cells that have been specially processed to remove certain immune cells, then combinin…
Matched conditions: EPITHELIOID SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Scientists map immune landscape of rare cancers
Knowledge-focused Recruiting nowThis study aims to learn more about how the immune system interacts with rare types of soft tissue sarcoma. Researchers will observe 400 adult patients in France who have one of nine specific rare sarcoma subtypes. The goal is to collect detailed biological and clinical informati…
Matched conditions: EPITHELIOID SARCOMA
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Doctors launch major study to map rare Cancer's journey
Knowledge-focused Recruiting nowThis Italian study aims to learn more about epithelioid sarcoma, a rare type of cancer. Researchers will follow 100 patients to see what treatments they receive and how the disease progresses over time. The goal is to gather information that could help improve future care by unde…
Matched conditions: EPITHELIOID SARCOMA
Sponsor: Italian Sarcoma Group • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC